Alessandra Oliva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alessandra Oliva has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Alfonso Reginelli
Precision Medicine Department, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
1 shared publication - Anna Russo
Precision Medicine Department, University of Campania “Luigi Vanvitelli”, Piazza Luigi Miraglia 2, 80138 Naples, Italy
1 shared publication - Antonio Granata
Nephrology and Dialysis Unit, “Cannizzaro” Emergency Hospital, Catania, Italy
1 shared publication - Antonio Segalotti
Radiology Unit, Department of Medical Surgical and Health Sciences, University Hospital of Cattinara, 34149 Trieste, Italy
1 shared publication - Barbara Ruaro
Department of Pulmonology, University Hospital of Cattinara, 34149 Trieste, Italy
1 shared publication - Elisa Baratella
Radiology Unit, Department of Medical Surgical and Health Sciences, University Hospital of Cattinara, 34149 Trieste, Italy
1 shared publication
Latest Publications
- Open Access
CEUS in Atypical Renal Cystic Masses: How, When and Why
Background/Objectives: Cysts are the most common kidney lesions identified in patients undergoing abdominal imaging, with ultrasound (US) typically serving as the initial diagnostic tool. Contrast-enhanced ultrasound (CEUS) has emerged as a highly effective modality for the evaluation of cystic renal lesions, particularly when conventional B-mode ultrasound (US) or CE-CT are inconclusive. While simple renal cysts are readily characterised on US, cystic renal lesions require further assessment. Methods: The Bosniak classification, originally developed for CE-CT, remains the cornerstone for categorising cystic renal lesions, guiding management from surveillance to surgical intervention. Recent efforts to standardise CEUS-specific imaging parameters and adapt the Bosniak criteria aim to improve interobserver agreement, reduce subjectivity, and enhance diagnostic accuracy. Results: CEUS offers superior sensitivity for detecting slow blood flow and minimal vascularity within septa, wall or solid components, often outperforming CE-CT in real-time vascular assessment. However, the high sensitivity of CEUS can reveal additional septa or subtle enhancement, potentially leading to lesion overscoring, if the different sensitivity of CEUS and CT/MRI for detecting enhancement is not taken into account. CEUS also plays a crucial role in the follow-up of non-surgical cystic lesions, providing a radiation-free and cost-effective alternative for long-term monitoring. Certain scenarios, such as post-interventional changes, traumatic cystic rupture, or infected cysts, fall outside the scope of the Bosniak system and require careful clinical correlation. Conclusions: By integrating CEUS into the diagnostic pathway, sonologists can achieve accurate lesion characterisation, optimise patient management, and minimise unnecessary invasive procedures, reinforcing CEUS as an essential tool in the evaluation and follow-up of complex renal cystic masses.
Open AccessCEUS in Atypical Renal Cystic Masses: How, When and Why
Background/Objectives: Cysts are the most common kidney lesions identified in patients undergoing abdominal imaging, with ultrasound (US) typically serving as the initial diagnostic tool. Contrast-enhanced ultrasound (CEUS) has emerged as a highly effective modality for the evaluation of cystic renal lesions, particularly when conventional B-mode ultrasound (US) or CE-CT are inconclusive. While simple renal cysts are readily characterised on US, cystic renal lesions require further assessment. Methods: The Bosniak classification, originally developed for CE-CT, remains the cornerstone for categorising cystic renal lesions, guiding management from surveillance to surgical intervention. Recent efforts to standardise CEUS-specific imaging parameters and adapt the Bosniak criteria aim to improve interobserver agreement, reduce subjectivity, and enhance diagnostic accuracy. Results: CEUS offers superior sensitivity for detecting slow blood flow and minimal vascularity within septa, wall or solid components, often outperforming CE-CT in real-time vascular assessment. However, the high sensitivity of CEUS can reveal additional septa or subtle enhancement, potentially leading to lesion overscoring, if the different sensitivity of CEUS and CT/MRI for detecting enhancement is not taken into account. CEUS also plays a crucial role in the follow-up of non-surgical cystic lesions, providing a radiation-free and cost-effective alternative for long-term monitoring. Certain scenarios, such as post-interventional changes, traumatic cystic rupture, or infected cysts, fall outside the scope of the Bosniak system and require careful clinical correlation. Conclusions: By integrating CEUS into the diagnostic pathway, sonologists can achieve accurate lesion characterisation, optimise patient management, and minimise unnecessary invasive procedures, reinforcing CEUS as an essential tool in the evaluation and follow-up of complex renal cystic masses.
- Open Access
CT Imaging Features of Pulmonary Sarcoidosis: Typical and Atypical Radiological Features and Their Differential Diagnosis
Sarcoidosis is a chronic, idiopathic, multisystemic inflammatory disease characterized by non-caseating granulomas, most commonly affecting the lungs and mediastinal lymph nodes. Radiological imaging plays a fundamental role in the diagnosis, assessment of disease extent, and differentiation from other pulmonary conditions. This narrative review offers a comprehensive overview of the imaging features of pulmonary sarcoidosis, focusing on both typical patterns—such as bilateral hilar lymphadenopathy, perilymphatic nodules, and upper lobe-predominant infiltrates—and atypical manifestations—including alveolar opacities, miliary nodules, fibrocystic changes, and lower lobe involvement. Emphasis is placed on the utility of high-resolution computed tomography (HRCT) in detecting early parenchymal changes and complications such as fibrosis, bronchiectasis, and pulmonary hypertension. Differential diagnosis, including tuberculosis, silicosis, metastatic disease, organizing pneumonia, and hypersensitivity pneumonitis, are discussed to aid interpretation. Recognizing the spectrum of radiological presentations is essential for distinguishing sarcoidosis from other interstitial and granulomatous lung diseases. Radiologists play a pivotal role in the multidisciplinary diagnostic process, contributing to timely diagnosis, risk stratification, and optimized patient management.
Open AccessCT Imaging Features of Pulmonary Sarcoidosis: Typical and Atypical Radiological Features and Their Differential Diagnosis
Sarcoidosis is a chronic, idiopathic, multisystemic inflammatory disease characterized by non-caseating granulomas, most commonly affecting the lungs and mediastinal lymph nodes. Radiological imaging plays a fundamental role in the diagnosis, assessment of disease extent, and differentiation from other pulmonary conditions. This narrative review offers a comprehensive overview of the imaging features of pulmonary sarcoidosis, focusing on both typical patterns—such as bilateral hilar lymphadenopathy, perilymphatic nodules, and upper lobe-predominant infiltrates—and atypical manifestations—including alveolar opacities, miliary nodules, fibrocystic changes, and lower lobe involvement. Emphasis is placed on the utility of high-resolution computed tomography (HRCT) in detecting early parenchymal changes and complications such as fibrosis, bronchiectasis, and pulmonary hypertension. Differential diagnosis, including tuberculosis, silicosis, metastatic disease, organizing pneumonia, and hypersensitivity pneumonitis, are discussed to aid interpretation. Recognizing the spectrum of radiological presentations is essential for distinguishing sarcoidosis from other interstitial and granulomatous lung diseases. Radiologists play a pivotal role in the multidisciplinary diagnostic process, contributing to timely diagnosis, risk stratification, and optimized patient management.
- Open Access
- 28 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (17) , 2179
AI-Based HRCT Quantification in Connective Tissue Disease-Associated Interstitial Lung Disease
Background: Interstitial lung disease (ILD) is a frequent and potentially progressive manifestation in patients with connective tissue diseases (CTDs). Accurate and reproducible quantification of parenchymal abnormalities on high-resolution computed tomography (HRCT) is essential for evaluating treatment response and monitoring disease progression, particularly in complex cases undergoing antifibrotic therapy. Artificial intelligence (AI)-based tools may improve consistency in visual assessment and assist less experienced radiologists in longitudinal follow-up. Methods: In this retrospective study, 48 patients with CTD-related ILD receiving antifibrotic treatment were included. Each patient underwent four HRCT scans, which were evaluated independently by two radiologists (one expert, one non-expert) using a semi-quantitative scoring system. Percentage estimates of lung involvement were assigned for four parenchymal patterns: hyperlucency, ground-glass opacity (GGO), reticulation, and honeycombing. AI-based analysis was performed using the Imbio Lung Texture Analysis platform, which generated continuous volumetric percentages for each pattern. Concordance between AI and human interpretation was assessed, along with mean absolute error (MAE) and inter-reader differences. Results: The AI-based system demonstrated high concordance with the expert radiologist, with an overall agreement of 81% across patterns. The MAE between AI and the expert ranged from 1.8% to 2.6%. In contrast, concordance between AI and the non-expert radiologist was significantly lower (60–70%), with higher MAE values (3.9% to 5.2%). McNemar’s and Wilcoxon tests confirmed that AI aligned more closely with the expert than the non-expert reader (p < 0.01). AI proved particularly effective in detecting subtle changes in parenchymal burden during follow-up, especially when visual interpretation was inconsistent. Conclusions: AI-driven quantitative imaging offers performance comparable to expert radiologists in assessing ILD patterns on HRCT and significantly outperforms less experienced readers. Its reproducibility and sensitivity to change support its role in standardizing follow-up evaluations and enhancing multidisciplinary decision-making in patients with CTD-related ILD, particularly in progressive fibrosing cases receiving antifibrotic therapy.
- 28 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (17) , 2179
Open AccessAI-Based HRCT Quantification in Connective Tissue Disease-Associated Interstitial Lung Disease
Background: Interstitial lung disease (ILD) is a frequent and potentially progressive manifestation in patients with connective tissue diseases (CTDs). Accurate and reproducible quantification of parenchymal abnormalities on high-resolution computed tomography (HRCT) is essential for evaluating treatment response and monitoring disease progression, particularly in complex cases undergoing antifibrotic therapy. Artificial intelligence (AI)-based tools may improve consistency in visual assessment and assist less experienced radiologists in longitudinal follow-up. Methods: In this retrospective study, 48 patients with CTD-related ILD receiving antifibrotic treatment were included. Each patient underwent four HRCT scans, which were evaluated independently by two radiologists (one expert, one non-expert) using a semi-quantitative scoring system. Percentage estimates of lung involvement were assigned for four parenchymal patterns: hyperlucency, ground-glass opacity (GGO), reticulation, and honeycombing. AI-based analysis was performed using the Imbio Lung Texture Analysis platform, which generated continuous volumetric percentages for each pattern. Concordance between AI and human interpretation was assessed, along with mean absolute error (MAE) and inter-reader differences. Results: The AI-based system demonstrated high concordance with the expert radiologist, with an overall agreement of 81% across patterns. The MAE between AI and the expert ranged from 1.8% to 2.6%. In contrast, concordance between AI and the non-expert radiologist was significantly lower (60–70%), with higher MAE values (3.9% to 5.2%). McNemar’s and Wilcoxon tests confirmed that AI aligned more closely with the expert than the non-expert reader (p < 0.01). AI proved particularly effective in detecting subtle changes in parenchymal burden during follow-up, especially when visual interpretation was inconsistent. Conclusions: AI-driven quantitative imaging offers performance comparable to expert radiologists in assessing ILD patterns on HRCT and significantly outperforms less experienced readers. Its reproducibility and sensitivity to change support its role in standardizing follow-up evaluations and enhancing multidisciplinary decision-making in patients with CTD-related ILD, particularly in progressive fibrosing cases receiving antifibrotic therapy.